Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study


Creative Commons License

CEYHAN M., KARADAĞ ÖNCEL E., Badur S., Ciblak M. A., Alhan E., Celik U. S., ...Daha Fazla

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.16, sa.4, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 4
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1016/j.ijid.2011.12.008
  • Dergi Adı: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Influenza, Children, Symptom duration, Oseltamivir, CHILDREN, BURDEN, HOSPITALIZATION, INFECTION, COMPLICATIONS, EPIDEMIOLOGY, OUTCOMES, THERAPY, ILLNESS, DISEASE
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: The aim of this multicenter prospective study was to evaluate the efficacy of a new bioequivalent formulation of oseltamivir for the treatment of influenza A, influenza B, and H1N1 during the 2010-2011 influenza season.